Skip to main content
SpringerLink
Log in

Implantable and Wearable Defibrillator Therapy

  • Chapter
  • First Online:
Cardiac Arrhythmias, Pacing and Sudden Death

Part of the book series: Cardiovascular Medicine ((CVM))

  • 1485 Accesses

Abstract

Based on the results of multiple prospective randomized trials, the implantable cardioverter defibrillator (ICD) has become the dominant strategy for primary and secondary prevention of sudden cardiac death. When used in conjunction with cardiac resynchronization therapy for patients with impaired left ventricular function, left bundle-branch block, and heart failure, ICDs have resulted in decreased heart failure hospitalizations and prolonged survival. These improved outcomes are also accompanied by reverse remodeling based on echo parameters. More recently, a totally subcutaneous implantable cardioverter defibrillator has been developed. While it eliminates the transvenous lead, it has no bradycardia or antitachycardia pacing. The role of the wearable cardiac defibrillator in prevention of sudden cardiac death in high-risk populations remains less clearly defined due to the absence of appropriate designed prospective randomized trials.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Myerburg RJ, Castellanos A. Cardiac arrest and sudden cardiac death. In: Braunwald E, editor. Heart disease: a textbook of cardiovascular medicine. 4th ed. Philadelphia: W.B. Saunders; 1992. p. 756–89.

    Google Scholar 

  2. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death. Structure, function, and time-dependence of risk. Circulation. 1992;85(Suppl 1):I2–10.

    CAS  PubMed  Google Scholar 

  3. Zhang ZJ, Croft JB, Giles WH, et al. Sudden cardiac death in the United States, 1989 to 1998. Circulation. 2001;104:2158.

    Article  Google Scholar 

  4. Estes NAM. Predicting and preventing sudden death. Circulation. 2011;124:651–6.

    Article  PubMed  Google Scholar 

  5. Kuck, KH, Cappato, R, Siebels, J, et al., for the CASH Investigators. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest. The Cardiac Arrest Study Hamburg (CASH). Circulation. 2000;102:748.

    Google Scholar 

  6. Connolly SJ, Gent M, Roberts RS, et al. Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000;101:1297.

    Article  CAS  PubMed  Google Scholar 

  7. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337:1576.

    Article  Google Scholar 

  8. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008;117:e350.

    Article  PubMed  Google Scholar 

  9. Epstein AE, JP DM, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; Heart Rhythm Society. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. 2013;127:e283–352.

    Article  PubMed  Google Scholar 

  10. Costantini O, Hohnloser SH, Kirk MM, et al., ABCD Trial Investigators. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention. J Am Coll Cardiol. 2009;53:471–9.

    Google Scholar 

  11. Chow T, Kereiakes DJ, Onufer J, et al., MASTER Trial Investigators. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial. J Am Coll Cardiol. 2008;52:1607–15.

    Google Scholar 

  12. La Rovere MT, Bigger JT Jr, Marcus FI, et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet. 1998;351:478–84.

    Article  PubMed  Google Scholar 

  13. http://www.cms.gov/medicare-coverage-database/details/ncd-details.aspx?NCDId=110&ncdver=3&NCAId=148&NcaName=Implantable+Defibrillators&IsPopup=y&bc=AAAAAAAAIAAA&. Accessed 31 Aug 2015.

  14. https://www.acls.net/aclsalg.htm

  15. Matchett M, Sears SF, Hazelton G, Kirian K, Wilson E, Nekkanti R. The implantable cardioverter defibrillator: its history, current psychological impact and future. Expert Rev Med Devices. 2009;6:43–50.

    Article  PubMed  Google Scholar 

  16. van Welsenes GH, Borleffs CJ, van Rees JB, Atary JZ, Thijssen J, van der Wall EE, Schalij MJ. Improvements in 25 years of implantable cardioverter defibrillator therapy. Neth Heart J. 2011;19:24–30.

    Article  PubMed  Google Scholar 

  17. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm321755.htm

  18. Bigger JT, for the Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. N Engl Med J. 1997;337:1569–75.

    Google Scholar 

  19. Moss, AJ, Hall, WJ, Cannom, DS, et al., for the Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335:1933.

    Google Scholar 

  20. Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 1999;341:1882.

    Article  CAS  PubMed  Google Scholar 

  21. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877.

    Article  PubMed  Google Scholar 

  22. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225.

    Article  CAS  PubMed  Google Scholar 

  23. Hohnloser SH, Kuck KH, Dorian P, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004;351:2481.

    Article  CAS  PubMed  Google Scholar 

  24. Steinbeck G, Andresen D, Seidl K, et al., for the IRIS Investigators. Defibrillator implantation early after myocardial infarction. N Engl J Med. 2009;361:1427–36.

    Google Scholar 

  25. Strickberger SA, Hummel JD, Bartlett TG, et al. Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia—AMIOVIRT. J Am Coll Cardiol. 2003;41:1707.

    Article  PubMed  Google Scholar 

  26. Bansch D, Antz M, Boczor S, et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation. 2002;105:1453.

    Article  PubMed  Google Scholar 

  27. Kadish A, Dyer A, Daubert JP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151.

    Article  CAS  PubMed  Google Scholar 

  28. Abraham W, Young J, León A, et al. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation. 2004;110:2864–8.

    Article  PubMed  Google Scholar 

  29. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140.

    Article  CAS  PubMed  Google Scholar 

  30. Moss AJ, Hall WJ, Cannom DS, et al., for the MADIT-CRT Trial Investigators. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361:1329–38.

    Google Scholar 

  31. Tang A, Wells GA, Talajic M, et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med. 2010;363:2385–95.

    Article  CAS  PubMed  Google Scholar 

  32. Linde C, Abraham WT, Gold MR, St John Sutton M, Daubert C, REVERSE Study Group. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol. 2008;52:1834–43.

    Article  PubMed  Google Scholar 

  33. Beshai JF, Grimm RA, Nagueh SF, Baker JH 2nd, Beau SL, Greenberg SM, Pires LA, Tchou PJ, RethinQ Study Investigators. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med. 2007;357:2461–71.

    Article  CAS  PubMed  Google Scholar 

  34. Frank Ruschitzka, William T. Abraham, Jagmeet P. Singh, Jeroen J. Bax, Jeffrey S. Borer, Josep Brugada, Kenneth Dickstein, Ian Ford, John Gorcsan III, Daniel Gras, Henry Krum, Peter Sogaard Johannes Holzmeister, for the EchoCRT Study Group. Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. N Engl J Med. 2013;369:1395–1405.

    Google Scholar 

  35. Maisel WH. Implantable cardioverter-defibrillator lead complication: when is an outbreak out of bounds? Heart Rhythm. 2008;5:1673–4.

    Article  PubMed  Google Scholar 

  36. Byrd CL, Wilkoff B, Love CJ, et al. Intravascular extraction of problematic or infected permanent pacemaker leads: 1994–1996, U.S. Extraction Database, MED Institute. Pacing Clin Electrophysiol. 1999;22:1348–57.

    Article  CAS  PubMed  Google Scholar 

  37. Wazni O, Epstein LM, Carrillo RG, et al. Lead extraction in the contemporary setting: the LExICon study: an observational retrospective study of consecutive laser lead extractions. J Am Coll Cardiol. 2010;55:579–86.

    Article  CAS  PubMed  Google Scholar 

  38. Gold MR, Weiss R, Theuns DA, Smith W, Leon A, Knight BP, Carter N, Husby M, Burke MC. Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator. Heart Rhythm. 2014;11:1352–8.

    Article  PubMed  Google Scholar 

  39. Killingsworth CR, Litovsky SH, Melnick SB, et al. Shocks delivered via a subcutaneous defibrillation system cause less acute injury than transvenous leads in swine. Heart Rhythm. 2010;7:S186.

    Google Scholar 

  40. Bardy GH, Smith WM, Hood MA, et al. An entirely subcutaneous implantable cardioverter–defibrillator. N Engl J Med. 2010;363:36–44.

    Article  CAS  PubMed  Google Scholar 

  41. Weiss R, Knight BP, Gold MR, Leon AR, Herre JM, Hood M, Rashtian M, Kremers M, Crozier I, Lee KL, Smith W, Burke MC. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation. 2013;128:944–53.

    Article  PubMed  Google Scholar 

  42. Burke MC, Gold MR, Knight BP, Barr CS, Theuns DA, Boersma LV, Knops RE, Weiss R, Leon AR, Herre JM, Husby M, Stein KM, Lambiase PD. Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE Study and EFFORTLESS Registry. J Am Coll Cardiol. 2015;65:1605–15.

    Article  PubMed  Google Scholar 

  43. Adler A, Halkin A, Viskin S. Wearable cardioverter-defibrillators. Circulation. 2013;127:854–60.

    Article  PubMed  Google Scholar 

  44. Feldman AM, Klein H, Tchou P, Murali S, Hall WJ, Mancini D, Boehmer J, Harvey M, Heilman MS, Szymkiewicz SJ, Moss AJ, WEARIT Investigators and Coordinators; BIROAD Investigators and Coordinators. Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT/BIROAD. Pacing Clin Electrophysiol. 2004;27:4–9.

    Article  PubMed  Google Scholar 

  45. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC Jr, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, American College of Cardiology/American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114:e385–484.

    Article  PubMed  Google Scholar 

  46. Chung MK, Szymkiewicz SJ, Shao M, et al. Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival. J Am Coll Cardiol. 2010;56:194–203.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Klein HU, Meltendorf U, Reek S, et al. Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD). Pacing Clin Electrophysiol. 2010;33:353–567.

    Article  PubMed  Google Scholar 

  48. Lee BK, Olgin JE. Role of wearable and automatic external defibrillators in improving survival in patients at risk for sudden cardiac death. Curr Treat Options Cardiovasc Med. 2009;11:360–5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA

    Samir Saba M.D., F.A.C.C., F.H.R.S.

  2. New England Arrhythmia Center, Tufts-New England Medical Center, Boston, MA, USA

    N. A. Mark Estes MD, FACC, FAHA, FHRS, FESC

Authors
  1. Samir Saba M.D., F.A.C.C., F.H.R.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. A. Mark Estes MD, FACC, FAHA, FHRS, FESC
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Samir Saba M.D., F.A.C.C., F.H.R.S. .

Editor information

Editors and Affiliations

  1. Lankenau Heart Institute and Jefferson Medical College, Philadelphia, Pennsylvania, USA

    Peter Kowey

  2. Associate Professor of Medicine, Duke University Medical Center, Duke Clinical Research Institute, Durham, North Carolina, USA

    Jonathan P. Piccini

  3. Bernard Trabin Chair in Cardiology Professor of Medicine Chief, Division of Cardiology, Associate Clinical Director Heart and Vascular Institute, Penn State University College of Medicine, Hershey, Pennsylvania, USA

    Gerald Naccarelli

  4. Professor Emeritus of Medicine Department of Medicine, Division of Cardiology, Section of Electrophysiology, Columbia University, New York, USA

    James A. Reiffel

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Saba, S., Mark Estes, N.A. (2017). Implantable and Wearable Defibrillator Therapy. In: Kowey, P., Piccini, J., Naccarelli, G., Reiffel, J. (eds) Cardiac Arrhythmias, Pacing and Sudden Death. Cardiovascular Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-58000-5_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-58000-5_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-57998-6

  • Online ISBN: 978-3-319-58000-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation